Phase 2 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with cancer of the bile ducts inside the liver (intrahepatic cholangiocarcinoma) or cancer of the gallbladder, confirmed by a tissue or cell sample
- Three separate surgeons have agreed that your tumor cannot be removed by surgery
- Your doctors expect you to live for at least 12 weeks
- You are generally able to carry out daily activities with little to no limitation (confirm with trial site)
- You are willing to take part and have signed a consent form agreeing to join the study
- You are able and willing to attend follow-up appointments and report any side effects as required by the study
Who may not be able to join:
- You are currently taking or have taken other anti-cancer drugs as part of another research study
- You have an active autoimmune disease or a history of one, such as lung inflammation, eye inflammation, bowel inflammation, liver inflammation, or thyroid problems, among others
- You have asthma that requires you to use a bronchodilator (a medication to open your airways) to manage it
- You have a condition that weakens your immune system, including HIV infection
- You have heart disease that is causing symptoms or is not well controlled
- You had a serious infection in the 4 weeks before starting the trial treatment
- You have previously received a transplanted organ or bone marrow/stem cells from another person
- You received a live vaccine (such as certain flu or travel vaccines) within 4 weeks before starting treatment
- You have had another type of cancer anywhere else in the body within the past 5 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-2223340123
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.